Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2018 Oct 23;97(4):409–414. doi: 10.1111/aos.13929

Metabolic syndrome and some of its components in relation to risk of cataract extraction. A prospective cohort study of men

Birgitta Ejdervik Lindblad 1,, Niclas Håkansson 2, Alicja Wolk 2
PMCID: PMC6587757  PMID: 30353683

Abstract

Purpose

To evaluate the relationship between metabolic syndrome and some of its components with the incidence of cataract extraction.

Methods

A population‐based prospective cohort with a total of 45 049 men, aged 45–79 years, from the Cohort of Swedish Men completed in 1997 a self‐administered questionnaire concerning anthropometric measurements and lifestyle factors. The men were followed from 1 January 1998 through 31 December 2012, and the cohort was matched with registers of cataract extraction. The main outcome measure was incident cases of age‐related cataract extraction.

Results

Over the 15‐years of follow‐up, 7573 incident cases of cataract extraction were identified. After controlling for potential confounders, the association between single components of metabolic syndrome, abdominal adiposity, diabetes and hypertension and risk of cataract extraction was rate ratio (RR): 1.04; 95% confidence interval (CI): 0.99–1.10, RR: 1.77; 95% CI: 1.64–1.92 and RR: 1.06; 95% CI 1.00–1.13, respectively. The risk of cataract extraction increased with increasing numbers of metabolic syndrome components (p < 0.0001). Men aged 65 years or younger at baseline with all three components of the metabolic syndrome had a relative risk of 2.43 (95% CI: 1.95–3.01) for cataract extraction.

Conclusion

In this cohort of middle‐aged and elderly men, metabolic syndrome with the combination of abdominal adiposity, diabetes and hypertension was associated with an increased risk for cataract extraction, especially among men aged 65 years or younger. These findings put emphasis on the importance of weight control and healthy lifestyle behaviours in order to prevent cataract.

Keywords: cataract, cohort studies, metabolic syndrome, risk factors

Introduction

Obesity is increasing worldwide. According to the World Health Organization (WHO), the prevalence of obesity has nearly tripled since 1975, and almost 40% of the adult global population are now overweight and 13% are obese (World Health Organisation 2015). Parallel with increasing obesity, the prevalence of diabetes (Guariguata et al. 2014) and hypertension (Kearney et al. 2005) is also rising.

The Metabolic syndrome (METS) is a cluster of metabolic risk factors for cardiovascular disease (CVD) and type 2 diabetes, which include obesity (particular abdominal adiposity), elevated blood glucose, high blood pressure and dyslipidemia (Alberti et al. 2009). METS has become a clinical and public health problem and is also associated with cancer as well as ocular diseases such as glaucoma (Newman‐Casey et al. 2011) and retinopathy (Chopra et al. 2012). Limited data exist on the association of METS with cataract, the leading cause of blindness in the world.

Only three prospective studies have examined the association between METS and cataract and/or cataract extraction (Lindblad et al. 2008; Tan et al. 2008; Ghaem Maralani et al. 2013).

We previously examined, in a prospective cohort among middle‐aged and elderly women, the association between METS and some of its components with risk of cataract extraction (Lindblad et al. 2008). Both METS and its single components such as abdominal adiposity, diabetes and hypertension were associated with increased risk of cataract extraction especially among women aged 65 years or less.

Lifestyle behaviour and prevalence of diseases may differ between men and women. In this prospective cohort study, we therefore intended to examine the association between METS and the components abdominal adiposity, diabetes and hypertension with risk of cataract extraction among middle‐aged and elderly men.

Materials and Methods

The Cohort of Swedish Men

The Cohort of Swedish Men (COSM) was established in late autumn 1997, among men living in two counties in central Sweden, in order to prospectively study the association between different lifestyle factors and major chronic diseases, where cataract was included. All men aged 45–79 years received by mail a self‐administered questionnaire concerning anthropometric measurements and lifestyle factors. The questionnaire included among others, questions about waist circumference, diagnoses of diabetes and hypertension, weight and height. Answers were obtained from 48 645 men (48.5%) who well represents the population of middle‐aged and elderly men in Sweden (Lindblad et al. 2014). We excluded men who sent in blank questionnaires (n = 92), men with a diagnosis of cancer (other than nonmelanoma skin cancer) before 1997 (n = 2592) or who died before baseline (n = 55). From the analysis, we excluded 857 men with cataract extraction before start of follow‐up in 1998. The final study cohort included 45 049 men at start of follow‐up for cataract extractions in January 1998.

The study was approved by the Regional Ethical Review Board at Karolinska Institutet (Stockholm, Sweden) and adhered to the tenets of the Declaration of Helsinki. Completion of the self‐administered questionnaire was considered to imply informed consent.

Assessment and definition of metabolic syndrome components

We defined metabolic syndrome according to the Joint Scientific Statement, approved 2009 by several major organizations among them the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity in order to unify the criteria for the metabolic syndrome (Alberti et al. 2009). According to these recommendations, the presence of any three of the following five risk factors constitutes the metabolic syndrome; ethnic‐specific elevated waist circumference, treatment for or elevated triglycerides or reduced high‐density lipoprotein (HDL) cholesterol, elevated fasting glucose or drug treatment of elevated glucose, and elevated blood pressure or antihypertensive drug treatment. We used waist ≥94 cm as cut‐off point of abdominal obesity for European men. As we had no information on triglyceride levels or HDL cholesterol in our study, we focused on central adiposity, diabetes and hypertension.

In this study, abdominal adiposity was estimated from self‐reported waist circumference values at baseline. Validity of self‐reported waist circumference has been reported to be high (Spearman r = 0.80) (Spencer et al. 2004). Current weight and height were obtained from the questionnaire. High validity has also been observed for self‐reported height (r = 0.91) and weight (r = 0.87) compared with actual measurements among Swedish men (Kuskowska‐Wolk et al. 1992). Body mass index (BMI) (kg/m2) as an expression for overall obesity was estimated from self‐reported weight and height. Information on hypertension was obtained from self‐report in the questionnaire, and diagnoses of diabetes were obtained by linkage of the cohort to the National Patient Register and the National Diabetes Register as well as from self‐report in the questionnaire.

Other exposures

From the questionnaire, we collected information on possible risk factors for cataract, including cigarette smoking (number of cigarettes smoked per day during several periods in life), alcohol consumption (frequencies and amounts of different beverages) use of corticosteroid medication, use of vitamin supplements, educational level and total physical activity.

Identification of incident cases and follow‐up of the cohort

Using personal identification numbers, we matched the cohort against computerized registers of cataract extraction in the study area and with the Swedish National Cataract Register, which covers 96% of all cataract extractions in Sweden. We used the International Classification of Diseases, 10th Revision (ICD 10), code H25 for age‐related cataract. Cataracts considered to be congenital, secondary to ocular trauma or intraocular inflammation and previous intraocular surgery (ICD10, code H26) were not included in the matching.

The cohort was followed until the date of cataract extraction, date of death or the end of the follow‐up period (31 December 2012), whichever came first.

The dates of deaths in the cohort were ascertained from the Swedish Death Register which is 100 percent complete.

Statistical analysis

We estimated relative risks as rate ratios (RRs) with 95% confidence intervals (CI), by Cox proportional hazards regression models, using sas (version 9.3; SAS Institute, Inc, Cary, NC, USA).

Relative risks were estimated for single components of the metabolic syndrome such as waist circumference, history of diabetes and hypertension, and for the metabolic syndrome (waist ≥94 cm for European men, diabetes and hypertension). Overall obesity measured as BMI (kg/m2) was categorized into five categories based on the WHO guidelines, underweight (BMI < 18.5), normal weight (BMI: 18.5–24.9), overweight (BMI: 25–29.9), obese I (BMI: 30–34.9) and obese II (BMI ≥ 35), and relative risks were estimated for categories of current BMI. In multivariate analysis, we adjusted for other potential risk factors, including age (5‐year age groups as incidence of cataract extraction with age is not linear; 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 and 75–79 years), smoking (number of cigarettes smoked per day during several periods in life, converted into mean number of cigarettes smoked per day and divided into, never, past and current ≤10, >10 cigarettes/day), alcohol consumption (frequencies and amount of different beverages, converted into grams of alcohol and divided into quartiles), use of corticosteroid medication (yes/no), use of vitamin supplement/yes/no), educational level (<10, 10–12, >12 years) and total physical activity (metabolic equivalent of the task (MET)hours/day, divided into quartiles, with the sum of different types of activities defined as multiples of MET (kcal/kg/hr) multiplied by self‐reported duration in hours for each activity). We stratified for age, using ≤65/>65 years as cut‐off point, as BMI in our cohort started to decline from age of 65 years. All reported p values are two‐sided, and p < 0.05 was considered statistically significant.

Results

We identified 7573 incident cases of cataract extraction during the study period 1 January 1998 through 1 December 2012. Almost 60% of the men in the cohort had signs of abdominal adiposity, with waist circumference more or equal to 94 cm and 26% had a waist circumference of more than 102 cm (cut‐off point for obesity in the WHO guidelines). The prevalence of diabetes and hypertension in the cohort was 7% and 22%, respectively. Men with metabolic syndrome had a higher alcohol consumption, used less vitamin supplement, had a lower educational level and had a lower physical activity compared with men without metabolic syndrome. Other baseline characteristics are presented in Table 1.

Table 1.

Baseline characteristics of the Cohort of Swedish Men 1997a by metabolic syndrome and its components

Waist ≥ 94 cm Hypertension Diabetes Metabolic syndrome
No Yes p No Yes p No Yes p No Yes pb
No. of men n 15 014 21 290 34 907 10 142 41 830 3219 12 358 880
Cataract extractions n 2319 3916 5483 2090 6656 917 1759 270
Age (years) mean 59 61 <0.0001 59 63 <0.0001 60 64 <0.0001 59 65 <0.0001
Never smoker % 34.9 37.5 <0.0001 34.8 37.2 0.0003 33.5 32.5 0.0016 41.9 34.7 <0.0001
Smokes 1‐10 cig/day % 6.9 8.1 <0.0001 6.7 8.0 <0.0001 6.2 6.1 0.0012 9.0 4.0 <0.0001
Smokes >10 cig/day % 14.5 15.8 0.04598 15.5 15.5 0.06811 18.2 17.6 0.0042 14.8 13.0 0.4965
Ex smoker % 43.6 38.6 <0.0001 43.1 39.4 <0.0001 42.1 40.8 0.0013 34.3 48.3 <0.0001
Alcohol consumption, g/day Mean 13.9 15.9 <0.0001 14.8 16.3 <0.0001 15.2 14.5 0.03260 13.9 16.4 <0.0001
Steroid use % 9.0 10.1 0.0011 9.1 11.4 <0.0001 9.5 11.6 0.0022 8.7 13.7 <0.0001
Vitamin supplement use % 33.7 30.0 <0.0001 30.6 30.8 0.8929 30.7 29.8 0.0307 33.6 27.1 .0003
BMI, kg/m2 Mean 23.5 27.3 <0.0001 25.4 27.1 <0.0001 25.7 27.4 <0.0001 23.4 29.5 <0.0001
Educational level, > 12 years % 18.5 14.7 <0.0001 17.0 13.3 <0.0001 16.5 12.8 <0.0001 18.9 11.6 <0.0001
Physical activity, MET hr/day Mean 42.2 41.2 <0.0001 41.7 41.1 <0.0001 41.6 41.0 <0.0001 42.3 40.4 <0.0001

BMI = body mass index, MET = metabolic equivalent of the task.

a

All values (except age) are standardized to the age distribution in the study population.

b

p‐values are obtained t‐test.

The association between the metabolic syndrome and some of its components simultaneously adjusted for each other and risk of cataract extraction is shown in Table 2. The multivariate‐adjusted relative risk for cataract extraction among men with waist circumference ≥94 cm was 1.04 (95% CI: 0.99–1.10), and among men with abdominal adiposity (waist > 102 cm), the relative risk was 1.08 (95% CI: 1.02–1.15).

Table 2.

Relative risk and 95% CI for cataract extraction by components of the metabolic syndrome and by age at baseline in the Cohort of Swedish Men 1997

RR (95% CI) RR (95% CI)a
Adjusted for age Multivariate model
Components of the metabolic syndrome
Waist circumference 94 cmb
All ages (n = 3916) 1.10 (1.0–1.16) 1.04 (0.99–1.10)
≤65 years (n = 1494) 1.11 (1.02–1.20) 1.05 (0.96–1.14)
>65 years (n = 2422) 1.09 (1.02–1.17) 1.04 (0.97–1.11)
Diabetes
All ages (n = 917) 1.82 (1.70–1.95) 1.77 (1.64–1.92)
≤65 years (n = 346) 2.23 (1.99–2.49) 2.07 (1.82–2.37)
>65 years (n = 571) 1.63 (1.50–1.78) 1.64 (1.48–1.81)
Hypertension
All ages (n = 2090) 1.17 (1.11–1.23) 1.06 (1.00–1.13)
≤65 years (n = 766) 1.29 (1.19–1.40) 1.17 (1.07–1.29)
>65 years (n = 1324) 1.10 (1.03–1.17) 1.00 (0.93–1.07)
All 3 components of the metabolic syndromec waist 94 cmb diabetes, and hypertension
All ages (n = 270) 2.09 (1.84–2.38) 2.04 (1.79–2.32)
≤65 years (n = 94) 2.45 (1.98–3.04) 2.43 (1.95–3.01)
>65 years (n = 176) 1.92 (1.63–2.25) 1.84 (1.57–2.17)

CI = confidence interval; RR = rate ratio.

a

Adjusted for age (5‐year age groups; 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79), smoking (never, past, current ≤10, >10 cigarettes/day), alcohol consumption (g/day in quartiles), steroid medication use (yes/no), vitamin supplement use (yes/no), educational level (<10, 10–12, >12 years), physical activity (metabolic equivalent of the task, hr/day in quartiles).

b

Waist cut‐off point for European men according to Joint Interim Statement (JIS)4.

c

Reference group is men without any of the three components of the metabolic syndrome.

There was a significant increased risk of cataract extraction with increasing number of components of the metabolic syndrome (p < 0.0001) (Table 3). Men with all three components of the metabolic syndrome (waist circumference ≥94 cm, diabetes and hypertension) had a twofold increased risk of cataract extraction (RR 2.04; 95% CI: 1.79–2.32) compared with men without any of these components (Table 3). Among men aged 65 years or younger, the relative risk was 2.43 (95% CI: 1.95–3.01).

Table 3.

Relative risk and 95% CI for cataract extraction according to the number of components of the metabolic syndrome at baseline in the Cohort of Swedish Men 1997

RR (95% CI) RR (95% CI)a
Adjusted for age Multivariate model
Components of the metabolic syndrome
None (n = 1759) 1.00 1.00
One of three (n = 2883) 1.09 (1.03–1.16) 1.07 (1.01–1.14)
Two of three (n = 1323) 1.25 (1.17–1.35) 1.22 (1.14–1.32)
All three (n = 270) 2.09 (1.84–2.38) 2.04 (1.79–2.32)
p for trend <0.0001 <0.0001

CI = confidence interval; RR = rate ratio.

a

Adjusted for age (5‐year age groups; 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79), smoking (never, past, current ≤10, >10 cigarettes/day), alcohol consumption (g/day in quartiles), steroid medication use (yes/no), vitamin supplement use (yes/no), educational level (<10, 10–12, >12 years), physical activity (metabolic equivalent of the task, hr/day in quartiles).

In our analyses, we found no overall association between BMI and risk of cataract extraction. Only among men with BMI ≥ 35 kg/m2, a statistically significant association with cataract extraction was observed (RR: 1.39; 95% CI: 1.15–1.68) compared with men with normal BMI.

Discussion

This large population‐based prospective cohort study, among middle‐aged and elderly men, confirms that metabolic syndrome is positively associated with increased risk of cataract extraction, especially among men aged 65 years or younger. Our results are consistent with our previous prospective cohort study among middle‐aged and elderly women in Sweden on the association between METS and cataract extraction (Lindblad et al. 2008). Two previous cross‐sectional studies, one from Korea (Park et al. 2014) and one from Lithuania (Paunksnis et al. 2007) reported a significant association between METS and cataract among women but not among men.

Our finding of an increased risk of cataract with increasing number of METS components complies with previous cohort (Lindblad et al. 2008), cross‐sectional (Sabanayagam et al. 2011; Park et al. 2014) and case–control studies (Galeone et al. 2010) both in the Western World (Lindblad et al. 2008; Galeone et al. 2010) and in Asia (Sabanayagam et al. 2011; Park et al. 2014).

Oxidative stress and an inflammatory mechanism are likely to contribute to the association between METS and cataract. The aetiology of cataract is multifactorial, and oxidative stress is of importance (Vinson 2006). C reactive protein (CRP) and pro‐inflammatory cytokines such as interleukin‐6 (IL‐6) and tumour necrosis factor‐α (TNF‐α) have been associated with cataract development (Schaumberg et al. 1999; Klein et al. 2006). Oxidative stress has also been associated with METS (Ando & Fujita 2009), and each component of METS has been associated with increased levels of CRP and cytokines (Bautista et al. 2005; Santos et al. 2005; Pou et al. 2007; Wang et al. 2013). A linear association with rising levels of CRP with increasing number of components of the metabolic syndrome (Ridker et al. 2003; Santos et al. 2005) is in concordance with a greater risk of cataract with increasing number of METS components.

We observed a weak positive association with central adiposity and cataract extraction. Central obesity has been related to cataract among cohort (Schaumberg et al. 2000; Jacques et al. 2003; Lindblad et al. 2008), cross‐sectional (Leske et al. 1999; Paunksnis et al. 2007) and case–control studies (Galeone et al. 2010).

Obesity, especially abdominal adiposity is associated with a chronic low‐grade state of inflammation (Santos et al. 2005). Among 1250 participants from the Framingham Heart Study, visceral adipose tissue was significantly related to CRP, IL‐6 and TNF‐α as well as with urinary isoprostanes, a marker of oxidative stress (Pou et al. 2007). An inflammatory mechanism connecting abdominal adiposity with cataract is supported by the findings from a nested case–control study within the Swedish mammography cohort where increased urinary levels of the isoprostane PGF2α were associated with increased risk of cataract extraction (Selin et al. 2014).

Diabetes is viewed as a risk factor for cataract. Our finding of an association between diabetes and cataract extraction is consistent with findings from cohort (Klein et al. 1998; Jacques et al. 2003; Lindblad et al. 2008; Tan et al. 2008; Ghaem Maralani et al. 2013), cross‐sectional (Leske et al. 1999; Sabanayagam et al. 2011; Richter et al. 2012; Park et al. 2014) and case–control studies (Galeone et al. 2010). Glucose uptake in the lens is an insulin‐independent process. A hyperosmotic effect in the lens may contribute to cataract development by activation of the polyol pathway where aldose reductase catalyses reduction of glucose to sorbitol. Accumulation of sorbitol leads to an osmotic gradient with infusion of fluid and swelling and rupture of the lens fibres (Kinoshita et al. 1979). Nonenzymatic glycation occurs during normal ageing of the lens where glucose reacts with amino groups on proteins and leads to formation and accumulation of advanced glycation end products (AGE) in the lens (Singh et al. 2014). Glycation has been found to occur at a higher degree in diabetic lenses. Interaction of AGE with cellular receptors (RAGE) also generates pro‐inflammatory cytokines such as interleukin‐1 α (IL‐1 α), IL‐6 and TNF‐α, indicating an inflammatory mechanism linking diabetes with cataract (Wang et al. 2013).

We observed a significant positive association between hypertension and cataract extraction. Previous cohort (Schaumberg et al. 2001; Lindblad et al. 2008; Tan et al. 2008), cross‐sectional (Leske et al. 1999; Paunksnis et al. 2007; Sabanayagam et al. 2011; Richter et al. 2012) and case–control studies (Galeone et al. 2010) have reported an association between hypertension and cataract, but results are inconsistent (Klein et al. 1998; Wang et al. 2009). An association between TNF‐α, IL‐6 (Bautista et al. 2005), CRP (Ridker et al. 2003) and hypertension has been reported indicating an underlying inflammatory mechanism linking hypertension with cataract (Schaumberg et al. 1999; Klein et al. 2006). Antihypertensive medication has also been reported to be associated with cataract. The Blue Mountain Eye Study reported in a 10‐year follow‐up study an association between β‐ blockers and both nuclear cataract and cataract extraction, which biologically could be explained by disturbance in electrolyte balance in the lens fibres (Kanthan et al. 2009). An association between potassium‐sparing diuretics and posterior subcapsular cataract was previously observed in the Beaver dam study (Klein et al. 2001), but the effect of anti‐hypertension medication could be explained by confounding by indication.

The strengths of our study include a population‐based prospective design with information on possible risk factors before cataract extraction, which minimize the risk for recall bias; a large study size; information on potential confounders and a long follow‐up which is almost complete.

There are, however, some potential limitations in our study. Misclassification of exposures may occur due to self‐reported measurements of waist circumference, weight and height. A previous study among men and women in Sweden reported a tendency for high values to be underestimated and low values to be overestimated (Kuskowska‐Wolk et al. 1992).

Some misclassification regarding history of diabetes and hypertension may also occur. However, we included information from several sources completing each other, as the National Patient Register, the National Diabetes Register and from self‐reports in the questionnaire. The prevalence of diabetes and hypertension in the cohort was in concordance with the prevalence among Swedish men in the same age group and time period (Statistics Sweden (SCB)). The prevalence of abdominal adiposity (>102 cm), diabetes and hypertension among men aged 60 in the study cohort was also similar to the prevalence among Swedish men in the same age group and time period in a Swedish study by Halldin et al. (Halldin et al. 2007); 23,0%, 7,3% and 23,8% versus 27,6%, 8,1% and 17,9%, respectively. Potential misclassification of anthropometric factors, diabetes and hypertension is, due to the prospective design of the study, likely to be similar for men who developed cataract and men who did not, which would weaken the observed association.

We had no information on triglyceride levels or HDL cholesterol and, therefore, had an underestimation of the metabolic syndrome which would attenuate the risk estimates.

Information on cataract subtype was not available. As lens opacity is clinically relevant only if visual function has declined considerably, we focused on the degree of cataract severe enough to affect activities of daily life, thus requiring lens extraction and, therefore, of greatest clinical, economic and public health importance. The mean preoperative best‐corrected visual acuity was, according to the Swedish National Cataract Register, 20/60 Snellen equivalents in the eye with cataract extraction compared with 20/32 Snellen equivalents in the unoperated eye during the study period.

There is a potential of bias as patients with diabetes are under regular ophthalmic care and, therefore, may have cataract extraction more easily. However, due to the Swedish healthcare system, all men in the study had the same access to cataract surgery with a patient fee less than $50 per operation. We cannot exclude a possibility for potential bias due to underestimation of cataract extraction, but this would lead to attenuation of the observed risk estimates (Rothman & Greenland 1998).

In this cohort of middle‐aged and elderly men, metabolic syndrome with the combination of abdominal adiposity, diabetes and hypertension was associated with a more than twofold increased risk of cataract extraction, especially among men aged 65 years or younger. These findings give emphasis to the importance of weight control and healthy lifestyle changes in order to prevent cataract in a time when obesity and metabolic syndrome have become a worldwide problem.

This work was supported by research grants from Örebro County Council, Örebro, Sweden.

There is no conflict of interest and the authors had no financial disclosures

References

  1. Alberti KG, Eckel RH, Grundy SM et al. (2009): Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640–1645. [DOI] [PubMed] [Google Scholar]
  2. Ando K & Fujita T (2009): Metabolic syndrome and oxidative stress. Free Radical Biol Med 47: 213–218. [DOI] [PubMed] [Google Scholar]
  3. Bautista LE, Vera LM, Arenas IA & Gamarra G (2005): Independent association between inflammatory markers (C‐reactive protein, interleukin‐6, and TNF‐alpha) and essential hypertension. J Hum Hypertens 19: 149–154. [DOI] [PubMed] [Google Scholar]
  4. Chopra R, Chander A & Jacob JJ (2012): Ocular associations of metabolic syndrome. Indian J Endocrinol Metab 16(Suppl 1): S6–S11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Galeone C, Petracci E, Pelucchi C, Zucchetto A, La Vecchia C & Tavani A (2010): Metabolic syndrome, its components and risk of age‐related cataract extraction: a case‐control study in Italy. Ann Epidemiol 20: 380–384. [DOI] [PubMed] [Google Scholar]
  6. Ghaem Maralani H, Tai BC, Wong TY, Tai ES, Li J, Wang JJ & Mitchell P (2013): Metabolic syndrome and risk of age‐related cataract over time: an analysis of interval‐censored data using a random‐effects model. Invest Ophthalmol Vis Sci 54: 641–646. [DOI] [PubMed] [Google Scholar]
  7. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U & Shaw JE (2014): Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103: 137–149. [DOI] [PubMed] [Google Scholar]
  8. Halldin M, Rosell M, de Faire U & Hellénius ML (2007): The metabolic syndrome: prevalence and association to leisure‐time and work‐related physical activity in 60‐year‐old men and women. Nutr Metab Cardiovasc Dis 17: 349–357. [DOI] [PubMed] [Google Scholar]
  9. Jacques PF, Moeller SM, Hankinson SE et al. (2003): Weight status, abdominal adiposity, diabetes, and early age‐related lens opacities. Am J Clin Nutr 78: 400–405. [DOI] [PubMed] [Google Scholar]
  10. Kanthan GL, Wang JJ, Rochtchina E & Mitchell P (2009): Use of antihypertensive medications and topical beta‐blockers and the long‐term incidence of cataract and cataract surgery. Br J Ophthalmol 93: 1210–1214. [DOI] [PubMed] [Google Scholar]
  11. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK & He J (2005): Global burden of hypertension: analysis of worldwide data. Lancet 365: 217–223. [DOI] [PubMed] [Google Scholar]
  12. Kinoshita JH, Fukushi S, Kador P & Merola LO (1979): Aldose reductase in diabetic complications of the eye. Metabolism 28: 462–469. [DOI] [PubMed] [Google Scholar]
  13. Klein BE, Klein R & Lee KE (1998): Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5‐year incidence of age‐related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126: 782–790. [DOI] [PubMed] [Google Scholar]
  14. Klein BE, Klein R, Lee KE & Danforth LG (2001): Drug use and five‐year incidence of age‐related cataracts: the Beaver Dam Eye Study. Ophthalmology 108: 1670–1674. [DOI] [PubMed] [Google Scholar]
  15. Klein BE, Klein R, Lee KE, Knudtson MD & Tsai MY (2006): Markers of inflammation, vascular endothelial dysfunction, and age‐related cataract. Am J Ophthalmol 141: 116–122. [DOI] [PubMed] [Google Scholar]
  16. Kuskowska‐Wolk A, Bergstrom R & Bostrom G (1992): Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord 16: 1–9. [PubMed] [Google Scholar]
  17. Leske MC, Wu SY, Hennis A, Connell AM, Hyman L & Schachat A (1999): Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 106: 35–41. [DOI] [PubMed] [Google Scholar]
  18. Lindblad BE, Håkansson N, Philipson B & Wolk A (2008): Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women. Ophthalmology 115: 1687–1692. [DOI] [PubMed] [Google Scholar]
  19. Lindblad BE, Håkansson N & Wolk A (2014): Smoking cessation and the risk of cataract: a prospective cohort study of cataract extraction among men. JAMA Ophthalmol 132: 253–257. [DOI] [PubMed] [Google Scholar]
  20. Newman‐Casey PA, Talwar N, Nan B, Musch DC & Stein JD (2011): The relationship between components of metabolic syndrome and open‐angle glaucoma. Ophthalmology 118: 1318–1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Park YH, Shin JA, Han K, Yim HW, Lee WC & Park YM (2014): Gender difference in the association of metabolic syndrome and its components with age‐related cataract: the Korea National Health and Nutrition Examination Survey 2008‐2010. PLoS ONE 9: e85068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paunksnis A, Bojarskiene F, Cimbalas A, Cerniauskiene LR, Luksiene DI & Tamosiunas A (2007): Relation between cataract and metabolic syndrome and its components. Eur J Ophthalmol 17: 605–614. [DOI] [PubMed] [Google Scholar]
  23. Pou KM, Massaro JM, Hoffmann U et al. (2007): Visceral and subcutaneous adipose tissue volumes are cross‐sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116: 1234–1241. [DOI] [PubMed] [Google Scholar]
  24. Richter GM, Torres M, Choudhury F, Azen SP & Varma R (2012): Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study. Ophthalmology 119: 547–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ridker PM, Buring JE, Cook NR & Rifai N (2003): C‐reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8‐year follow‐up of 14 719 initially healthy American women. Circulation 107: 391–397. [DOI] [PubMed] [Google Scholar]
  26. Rothman K & Greenland S (1998): Precision and validity in epidemiologic studies In: Rothman K, Greenland S. (eds) Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 11: 5–134. [Google Scholar]
  27. Sabanayagam C, Wang JJ, Mitchell P, Tan AG, Tai ES, Aung T, Saw SM & Wong TY (2011): Metabolic syndrome components and age‐related cataract: the Singapore Malay eye study. Invest Ophthalmol Vis Sci 52: 2397–2404. [DOI] [PubMed] [Google Scholar]
  28. Santos AC, Lopes C, Guimarães JT & Barros H (2005): Central obesity as a major determinant of increased high‐sensitivity C‐reactive protein in metabolic syndrome. Int J Obes (Lond) 29: 1452–1456. [DOI] [PubMed] [Google Scholar]
  29. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR & Hennekens CH (1999): High levels of plasma C‐reactive protein and future risk of age‐related cataract. Ann Epidemiol 9: 166–171. [DOI] [PubMed] [Google Scholar]
  30. Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE & Hennekens CH (2000): Relations of body fat distribution and height with cataract in men. Am J Clin Nutr 72: 1495–1502. [DOI] [PubMed] [Google Scholar]
  31. Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Stürmer T & Hennekens CH (2001): A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 11: 104–110. [DOI] [PubMed] [Google Scholar]
  32. Selin JZ, Lindblad BE, Rautiainen S, Michaëlsson K, Morgenstern R, Bottai M, Basu S & Wolk A (2014): Are increased levels of systemic oxidative stress and inflammation associated with age‐related cataract? Antioxid Redox Signal 21: 700–704. [DOI] [PubMed] [Google Scholar]
  33. Singh VP, Bali A, Singh N & Jaggi AS (2014): Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18: 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Spencer EA, Roddam AW & Key TJ (2004): Accuracy of self‐reported waist and hip measurements in 4492 EPIC‐Oxford participants. Public Health Nutr 7: 723–727. [DOI] [PubMed] [Google Scholar]
  35. Statistics Sweden (SCB) . Health and medical care 1980‐2006. Living conditions (ULF). Available at http://www.statistikdatabasen.scb.se/pxweb/sv/ssd/START__LE__LE0101__LE0101X/ULFHalsaR/?rxid=f45f90b6-7345-4877-ba25-9b43e6c6e299. Accessed 23 Feb, 2018.
  36. Tan JS, Wang JJ & Mitchell P (2008): Influence of diabetes and cardiovascular disease on the long‐term incidence of cataract: the Blue Mountains eye study. Ophthalmic Epidemiol 15: 317–327. [DOI] [PubMed] [Google Scholar]
  37. Vinson JA (2006): Oxidative stress in cataracts. Pathophysiology 13: 151–162. [DOI] [PubMed] [Google Scholar]
  38. Wang S, Xu L, Jonas JB et al. (2009): Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology 1116: 2373–2380. [DOI] [PubMed] [Google Scholar]
  39. Wang X, Bao W, Liu J et al. (2013): Inflammatory markers and risk of type 2 diabetes: a systematic review and meta‐analysis. Diabetes Care 36: 166–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. World Health Organisation . 2015. Obesity and overweight. Fact sheet N 311. Available at http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 23 Feb, 2018.

Articles from Acta Ophthalmologica are provided here courtesy of Wiley

RESOURCES